Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
In patients with early triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy, followed by adjuvant pembrolizumab after surgery, resulted in significantly lo...